Statins yield CV benefits for patients with type 2 diabetes

September 2004
Geriatrics;Sep2004, Vol. 59 Issue 9, p33
Academic Journal
The article focuses on the benefits of statins to cardiovascular (CV) patients. Physician Helen Colhoun reported that atorvastatin has been shown to reduce the risk of a first major CV event in patients with type 2 diabetes. She presented the results of the Collaborative Atorvastatin Diabetes Study (CARDS), the first trial of a lipid-modifying agent for the primary prevention of cardiovascular disease conducted solely in patients with type 2 diabetes. The study included 2,838 patients with type 2 diabetes and low density lipoprotein cholesterol levels of less than or equal to 160 mg/dL who had no clinical history of coronary, cerebrovascular, or severe peripheral vascular disease.


Related Articles

  • Statins, everyone? O'Neill, Simon // Practice Nursing;Feb2008, Vol. 19 Issue 2, p58 

    The author reflects on the use of statins by diabetic patients who develop cardiovascular disease (CVD). He states that many people with diabetes are failing to reach the recommendations and treatment targets for the CVD risk factors. He notes that many diabetics have benefited from statins...

  • COMMENTARY: Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus. Gami, Apoor S.; Smith, Steven A. // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p29 

    The article reports that atorvastatin reduces major cardiovascular disease (CVD) events in type 2 diabetes mellitus. Patients with type 2 diabetes and other risk factors for coronary artery disease or retinopathy had a 35 percent relative risk reduction in CVD attributed to atorvastatin....

  • Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events. Rajpathak, Swapnil N. // Evidence Based Medicine;Apr2012, Vol. 17 Issue 2, p55 

    The article discusses the comparison of intensive statin therapy with moderate dose that increases the risk of new onset diabetes but lowers the risk of cardiovascular (CVD) events. It mentions that meta-analyses of randomised trials have newly recommended that making use of statin is associated...

  • Statin Therapy May Reduce HD Patients' CV Risks.  // Renal & Urology News;May2011, Vol. 10 Issue 5, p5 

    The article discusses a study which reveals that statin therapy may reduce the risk of all-cause mortality events in hemodialysis (HD) patients, such as cardiovascular (CV) diseases.

  • Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes. Siyambalapitiya, Sajith; Bulugahapitiya, Uditha; Sithole, Jabulani; Song, Soon; Fernando, Devaka J. S.; Idris, Iskandar // Diabetes Care;Aug2007, Vol. 30 Issue 8, p2025 

    OBJECTIVE -- Strategies for initiating statin use among adult patients with diabetes for primary cardiovascular disease (CVD) prevention include treating all patients (assuming diabetes is a coronary risk equivalent) or treating patients who are at risk of developing CVD. The aim of the study...

  • Cholesterol truths Managing this risk factor. Rhéaume, Kate // Alive: Canada's Natural Health & Wellness Magazine;Feb2009, Issue 316, p120 

    The article provides information on managing high cholesterol. It is said that high cholesterol is only one risk factor for eventually developing cardiovascular disease. According to the author, taking statins to reduce cholesterol by merely blocking its production and not addressing its cause...

  • Groups Release New, Updated Guidelines to Reduce Heart Disease Risk Factors. Mitka, Mike // JAMA: Journal of the American Medical Association;12/25/2013, Vol. 310 Issue 24, p2602 

    The article reports on lipid control and lifestyle guidelines for prevention and treatment strategies to fight cardiovascular disease risk factors released by the American College of Cardiology, the American Heart Association and the Obesity Society in November 12, 2013. Details of previous...

  • Should statins be prescribed to people at low risk of cardiovascular disease? Abramson, John D.; Rosenberg, Harriet G.; Jewell, Nicholas; Wright, James M. // BMJ: British Medical Journal;10/26/2013, Vol. 347 Issue 7930, p15 

    The article argues that statins should not be prescribed for people with a 10 year risk of less than 10 percent of cardiovascular disease. The authors disagree with the changes in the 2013 Cochrane review of primary prevention with statins. He highlights the limitations of data and discusses the...

  • Cochrane review group responds to Abramson and colleagues' article on statins in low risk people. Huffman, Mark; Taylor, Fiona; Ebrahim, Shah; Abramson, John D.; Rosenberg, Harriet G.; Jewell, Nicholas; Wright, James M. // BMJ: British Medical Journal;3/8/2014, Vol. 348 Issue 7948, p26 

    The article presents the response of Mark Huffman and colleagues to the Cochrane Review on the use of statins as initial prevention for cardiovascular disease which was published in an article in the "British Medical Journal" and the corresponding response of the critics in defense of their...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics